1. Powering Pediatrics Studies: Meeting the FDA's Pharmacometrics Criteria Using Phoenix NLME & Trial Simulator

    57:28

    from Certara / Added

    14 Plays / / 0 Comments

    Effective medications are a mainstay of modern pediatric medicine. Yet, ethical concerns about conducting clinical trials in pediatric patients are a major challenge in pediatric drug development. Learn how Dr. Samer Mouksassi and his team at Pharsight Consulting Services have overcome these challenges through the use of pharmacometrics.

    + More details
    • A first look at Phoenix Trial Designer, the successor to Trial Simulator

      56:39

      from Certara / Added

      8 Plays / / 0 Comments

      This webinar will demonstrate a simulation of a case study using the prototype of Phoenix Trial Designer, which is actively being developed by Certara. The webinar will update interested users on the progress of the software, show the proposed design of the tool, discuss its dependencies, and outline intended capabilities for the first version of this product. Future plans for the tool following the first release will also be discussed. To help guide decisions on the development of this product, we will gather feedback from M&S scientists attending this webinar in a Q&A session. The intended audience is scientists familiar with Pharsight Trial Simulator who are interested in the successor software, Phoenix Trial Designer.

      + More details
      • Orphan Drug Congress Nov 2013: Part 3, How to Help Inexperienced Sites Conduct Successful Studies

        06:50

        from Premier Research / Added

        42 Plays / / 0 Comments

        WODC Europe Panel Discussion Making Clinical Trials Feasible November 14, 2013 Part 3: How to Help Inexperienced Sites Conduct Successful Studies

        + More details
        • Orphan Drug Congress April 2013: Part 1, Approaches to Clinical Trial Design

          20:28

          from Premier Research / Added

          304 Plays / / 0 Comments

          Approaches to Clinical Trial Design: Biomarkers, Adaptive Design, etc. Learn more about our Rare Disease and Orphan Drug Development capabilities here: http://premier-research.com/our-experience/rare-disease/

          + More details
          • CTTI Central IRB Recommendations Could Speed Development of New Medical Therapies

            03:25

            from CTTI / Added

            85 Plays / / 0 Comments

            CTTI central IRB recommendations could speed development of new medical therapies by eliminating inefficiencies. This video pertains to CTTI's Central IRB Project: http://www.ctti-clinicaltrials.org/what-we-do/study-start/central-irb *The views and opinions expressed in this video are those of the speaker and do not necessarily reflect the official policy or position of CTTI.

            + More details

            What are Tags?

            Tags

            Tags are keywords that describe videos. For example, a video of your Hawaiian vacation might be tagged with "Hawaii," "beach," "surfing," and "sunburn."